ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
American Bio Medica Corporation (CE)

American Bio Medica Corporation (CE) (ABMC)

0.0001
0.00
(0.00%)
Closed December 21 4:00PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.0001
Bid
0.00
Ask
0.00
Volume
-
0.00 Day's Range 0.00
0.000001 52 Week Range 0.002
Market Cap
Previous Close
0.0001
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
39,863
Shares Outstanding
48,098,476
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-0.03
Revenue
913k
Net Profit
-1.41M

About American Bio Medica Corporation (CE)

American Bio Medica Corporation is a biotechnology company that develops, manufactures and markets accurate, cost-effective immunoassay test kits, including some of the world's most effective point-of-collection tests for drugs of abuse. American Bio Medica Corporation is a biotechnology company that develops, manufactures and markets accurate, cost-effective immunoassay test kits, including some of the world's most effective point-of-collection tests for drugs of abuse.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Kinderhook, New York, USA
Founded
-
American Bio Medica Corporation (CE) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker ABMC. The last closing price for American Bio Medica (CE) was $0. Over the last year, American Bio Medica (CE) shares have traded in a share price range of $ 0.000001 to $ 0.002.

American Bio Medica (CE) currently has 48,098,476 shares outstanding. The market capitalization of American Bio Medica (CE) is $4,809.85 . American Bio Medica (CE) has a price to earnings ratio (PE ratio) of 0.00.

ABMC Latest News

Bulls Take Charge of Alternet Systems, Inc. (OTCMKTS: ALYI)

July 14, 2020 -- InvestorsHub NewsWire -- via Microcap Daily -- BY ALEX CARLSON ON JULY 13, 2020           Alternet Systems, Inc...

ABMC Reports Fourth Quarter and Year End 2014 Results

--Announces Refinancing of its Series A Debentures and Mortgage-- American Bio Medica Corporation (OTCQB:ABMC) today announced financial results for the fourth quarter and year ended...

ABMC Reports Third Quarter 2014 Results

American Bio Medica Corporation (OTCQB: ABMC) today announced financial results for the three and nine months ended September 30, 2014, Net sales for the third quarter of 2014 were...

ABMC Reports Second Quarter 2014 Results

American Bio Medica Corporation (OTCQB:ABMC) today announced financial results for the three and six months ended June 30, 2014. Net sales for the second quarter of 2014 were $1,811,000...

ABMC Reports First Quarter 2014 Results

American Bio Medica Corporation (OTCQB:ABMC) today announced financial results for the three months ended March 31, 2014. Net sales for the first quarter of 2014 were $2,043,000, a...

ABMC Reports Fourth Quarter and Year End 2013 Results

American Bio Medica Corporation (OTCQB:ABMC) today announced financial results for the fourth quarter and year ended December 31, 2013. Net sales in the fourth quarter of 2013 were...

ABMC Reports Third Quarter 2013 Results

American Bio Medica Corporation (OTCQB:ABMC) today announced financial results for the three and nine months ended September 30, 2013, and commented on the recent death of its former CEO...

ABMC Reports Second Quarter 2013 Results

American Bio Medica Corporation (OTCQB:ABMC) today announced financial results for the three and six months ended June 30, 2013. Net sales for the second quarter of 2013 were $2,380,000...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.00010.00010.0001398000.0001CS
4000.00010.00011.0E-61003213.376E-5CS
12000.00010.00011.0E-6398633.905E-5CS
26000.00010.00021.0E-6338728.249E-5CS
52-0.0001-500.00020.0021.0E-6360390.00034057CS
156-0.0349-99.71428571430.0350.04181.0E-6607490.01329378CS
260-0.0699-99.85714285710.071.261.0E-62151990.23603625CS

ABMC - Frequently Asked Questions (FAQ)

What is the current American Bio Medica (CE) share price?
The current share price of American Bio Medica (CE) is $ 0.0001
How many American Bio Medica (CE) shares are in issue?
American Bio Medica (CE) has 48,098,476 shares in issue
What is the market cap of American Bio Medica (CE)?
The market capitalisation of American Bio Medica (CE) is USD 4.81k
What is the 1 year trading range for American Bio Medica (CE) share price?
American Bio Medica (CE) has traded in the range of $ 0.000001 to $ 0.002 during the past year
What is the cash to sales ratio of American Bio Medica (CE)?
The cash to sales ratio of American Bio Medica (CE) is 0
What is the reporting currency for American Bio Medica (CE)?
American Bio Medica (CE) reports financial results in USD
What is the latest annual turnover for American Bio Medica (CE)?
The latest annual turnover of American Bio Medica (CE) is USD 913k
What is the latest annual profit for American Bio Medica (CE)?
The latest annual profit of American Bio Medica (CE) is USD -1.41M
What is the registered address of American Bio Medica (CE)?
The registered address for American Bio Medica (CE) is 122 SMITH ROAD, KINDERHOOK, NEW YORK, 12106
What is the American Bio Medica (CE) website address?
The website address for American Bio Medica (CE) is www.abmc.com
Which industry sector does American Bio Medica (CE) operate in?
American Bio Medica (CE) operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ELIQQElectriq Power Holdings Inc (CE)
$ 0.10
(99,900.00%)
100
GNTLFGenetic Technologies Ltd (PK)
$ 1.00
(90,809.09%)
100
VIVEViveve Medical Inc (CE)
$ 0.0003
(29,900.00%)
7.33k
BTIMBoatim Inc (CE)
$ 0.0002
(19,900.00%)
799
CLVRClever Leaves Holdings Inc (CE)
$ 0.0002
(19,900.00%)
592
RAASYCloopen Group Holding Limited (CE)
$ 0.000001
(-100.00%)
214
EWGFFEat Well Investment Group Inc (CE)
$ 0.000001
(-100.00%)
47.01k
SOLBFSoLVBL Solutions Inc (CE)
$ 0.000001
(-99.99%)
10k
HAVLFHavn Life Sciences Inc (CE)
$ 0.000001
(-99.98%)
4.02k
ENDRFEndor AG (GM)
$ 0.0001
(-99.98%)
560
HMBLHUMBL Inc (PK)
$ 0.00095
(5.56%)
344.89M
PHILPHI Group Inc (PK)
$ 0.0003
(0.00%)
312.21M
PLPLPlandai Biotechnology Inc (PK)
$ 0.0001
(0.00%)
215.71M
RDARRaadr Inc (PK)
$ 0.0014
(16.67%)
174.96M
CHNVFChina Youzan Ltd (PK)
$ 0.0177
(10.63%)
100M

ABMC Discussion

View Posts
Renee Renee 2 months ago
ABMC: SEC Admin. Proceeding for severely delinquent Financials (10Q for March 2023):

https://www.sec.gov/files/litigation/admin/2024/34-101284.pdf
👍️0
JJ24 JJ24 1 year ago
Melissa Waterhouse no longer listed as CEO !
👍️0
Ronin Ronin 1 year ago
Is this coming to life?

Not sure who owns the ticker now…
👍️0
micromillionaire micromillionaire 2 years ago
$ABMC Now we wait for a profitable company to take our ticker to new levels.... Hold tight and load up on cheapies!!! micro
👍️0
jw246802005 jw246802005 2 years ago
Waterhouse is GONE?? What now??

If the following copy/paste is correct, then Waterhouse is GONE.

In connection with the Sale, Melissa A. Waterhouse, the Chief Executive Officer/Principal Financial Officer of the Company, agreed to enter into an employment agreement with the Buyer. Therefore, the employment agreement with the Company’s Chief Executive Officer/ Principal Financial Officer, Melissa Waterhouse, was terminated effective March 1, 2023. Ms. Waterhouse has agreed to provide consulting services for the Company for up to three months, or until June 1, 2023 to assist with the Company’s financial reporting obligations and to assist with the Company’s efforts to secure a new line of business and enter into possible business combinations using the Company’s publicly traded stock as transaction consideration thereby enhancing shareholder value. Ms. Waterhouse will receive a monthly retainer in the amount of $4,000 for her consulting services; however, Ms. Waterhouse has agreed to suspend payment of the retainer until receipt of the Company’s ERC refund of $202,000 or release of the $300,000 in the retention fund previously referenced, whichever comes first. In addition, Ms. Waterhouse has agreed to accept payment of a loan provided to the Company in the amount of $43,000 upon closing of the Sale and suspend payment of her deferred salary in the amount of $92,000 and current salary owed to her in the amount of $29,000 until receipt of the Company’s ERC refund of $202,000 or release of the $300,000 in the retention fund previously referenced; whichever comes first.
👍️0
oldhamtrader oldhamtrader 2 years ago
Top filing on this link shows the moneys owed. I don't see much of anything happening for the next 3 months if Ms Waterhouse's past performance is any indication. Not sure what will happen after that.
https://fintel.io/sf/us/abmc
👍️0
meluto meluto 2 years ago
this sale got us out of a dying poor business and stopped the money drain (and the $15,000 on the CEO as a consultant for the next 3 months is probably a lot less then the loss that would have occurred during that time.)

I've not dug into the finances so I don't know if the sale left the company cash wise in a positive or a negative once all the debt was paid off. (I would not imagine much positive if there is.)

The company has value, how much I don't know. Perhaps someone might want to merge with them to become a very old company and get the tax credits. (At least someone else mentioned that to me previously that had a merger in mind)

I would hope the larger stock owners (who are down quite a decent amount of money would arrange something to happen with the company so they get their money back and aim to get a profit.)
👍️0
meluto meluto 2 years ago
value, but how much?

Someone might want to merge with them to become a very old company and get the tax credits. (At least someone else mentioned that to me previously that had a merger in mind)

I would hope the larger stock owners (who are down quite a decent amount of money would arrange something to happen with the company so they get their money back and aim to get a profit.)
👍️0
oldhamtrader oldhamtrader 2 years ago
From the way it looks there will not be much if any meat left on the bone. The CEO, Ms Waterhouse will stay on for 3 months earning $5k/mo as a consultant. Basically, what will be left is a shell for a new company to possibly go public with. Not sure what that is worth but doubt much.
I've been in the market for decades and this is one of the worst run companies I have seen, other than ones who turned out to be complete scams. Sad because the company had such potential at one time.
👍️0
GeneralZ GeneralZ 2 years ago
So, being ignorant of how this works , what does this sale do for shareholders?
👍️0
meluto meluto 2 years ago
Details out on the approved sale

https://www.sec.gov/ix?doc=/Archives/edgar/data/896747/000165495423002266/abmc_8k.htm
👍️0
oldhamtrader oldhamtrader 2 years ago
Still have the same leadership so we should not expect things to change any time soon.
👍️0
JJ24 JJ24 2 years ago
Looks like asset sale was approved . Now we wait to see what new direction the company goes in.
👍️0
radly radly 2 years ago
No The real dicks are the ones here that were pumping this stock to no end every day saying how it was going to the moon. I don't know how people list money or what that even means but I also lost a little here.
👍️ 1
Ronin Ronin 2 years ago
Thank you!
👍️0
Ronin Ronin 2 years ago
Thank you!
👍️0
oldhamtrader oldhamtrader 2 years ago
Yes, and under the terms, if no one is appointed before sale goes through, Melissa will stay on as a consultant for 3 months. This would further drain funds.
👍️0
JJ24 JJ24 2 years ago

Q. WHAT WILL HAPPEN IF THE ASSET SALE IS APPROVED BY SHAREHOLDERS?

A. If the holders of at least a majority of all of the outstanding shares of Common Stock approve the Asset Sale, and the conditions to closing the Asset Sale as set forth in the Asset Purchase Agreement are satisfied or waived, ABMC will sell substantially all of their assets to the Buyer for cash. As soon as practicable after the closing of the Asset Sale, ABMC plans to use net proceeds from the Asset Sale to address the outstanding liabilities of ABMC and continue to seek strategic acquisitions using ABMC’s publicly traded stock as transaction consideration. Such strategic acquisitions would result in ABMC entering a new line of business.
👍️0
Ronin Ronin 2 years ago
You’re a real dick…

People list lots money here, and you rub it in.


Vermin….
👍️ 1
Ronin Ronin 2 years ago
So new company is private? Our shares must be surrendered?
👍️0
meluto meluto 2 years ago
A "no" means three more months of the company continuing in which it is loosing money per month; what does that do for us (which includes 3 more months of paying fully to Melissa)?

If the board feels Melissa is needed for the 3 months then yes she would stay in an advisor role.
👍️0
jw246802005 jw246802005 2 years ago
Anyone go to the meeting?
👍️0
oldhamtrader oldhamtrader 2 years ago
It's a no for me. Why don't they just distribute the funds? If this passes, Melissa is going to stay as an advisor for 3 months, which will further drain funds. After that period, no one will be left unless she finds someone in those 3 months.
Better to get the .06 now then nothing later.
👍️0
meluto meluto 2 years ago
special meeting vote tomorrow

If you own, have you voted?

CEO leaving along with the bad business line they are in*, praying they get into a much better line soon.

*I think any current stock holders should agree to the sale. I don't think there is a choice as it is a dying** business.

** Most here would probably say this is because of the current leadership, however as that is not changing, unless there is a sale, it will just continue to die and better to get what money can be gotten from the current sale offer.
👍️0
radly radly 2 years ago
I haven't checked this stock/board in about 2 years. So when do the Fireworks start? Bah ha ha ha Everone was saying this was undervalued at .75. Bah ha ha ha. All were saying we know what we own Bah ha ha ha. Typical OTC message board! You guys still waiting for the Fireworks to begin any day now. Bah ha ha ha
👍️0
meluto meluto 2 years ago
CEO leaving along with the bad business line they are in*, praying they get into a much better line soon.

*I am assuming any current stock holders agree to the sale. I don't think there is a choice as it is a dying** business.

** Most here would probably say this is because of the current leadership, however as that is not changing it will just continue to die and better to get what money can be gotten from the current sale offer.
👍️0
sweetboodabud sweetboodabud 2 years ago
The Ceo of this company is a fraud,that's why they can't raise capital like other companies do.
👍️0
meluto meluto 2 years ago
Seems to me they are on the OTCQB, do you have something different?

I see it in the list at: https://stockmarketmba.com/listofotcqbstocks.php

The uplist to the OTCQB:
https://www.nasdaq.com/press-release/abmc-uplists-to-the-otcqb-venture-market-2020-12-02
👍️0
sweetboodabud sweetboodabud 2 years ago
Did this stovk go to pink from a tier they paid for?
👍️0
Ronin Ronin 2 years ago
Someone slowly accumulating here, like the workers who can only afford to buy a few hundred or thousand at a time.

Big news coming... I'm thinking gov't contract.
👍️0
JJ24 JJ24 2 years ago
Still holding a few here and thinking about getting some more .
👍️0
Bobinsd Bobinsd 2 years ago
What's nice?
👍️0
Ronin Ronin 2 years ago
Contract soon?
👍️0
Ronin Ronin 2 years ago
Contract soon?
👍️0
ChuckBits ChuckBits 2 years ago
Let's hope...
👍️0
Ronin Ronin 2 years ago
Really nice 10q…
Somthin brewing
👍️0
meluto meluto 2 years ago
Who is John

John J. Moroney from Landmark Pegasus

The following 8-K discusses his role with ABMC.

The 8-K by ABMC announcing there relationship
👍️0
jw246802005 jw246802005 2 years ago
Who is John that you just mentioned?

What is his job that is helping?
👍️0
meluto meluto 2 years ago
I bought some more today (as a trade I have enough long term), we'll see if John working with Melissa can get something positive going.
👍️0
ChuckBits ChuckBits 3 years ago
I heard they're working on a Monkeypox test! It's gonna be huge.

(That's what the voices in my head told me)
👍️0
meluto meluto 3 years ago
No one is head of sales for a while

That is a big part of the problem in my opinion.
👍️0
jw246802005 jw246802005 3 years ago
Maybe, this forced on her??

If itwas, it hasn't helped one Iota yet.
👍️0
jw246802005 jw246802005 3 years ago
Stuart Sternberg Active??

Does ANYONE know if the bigger ABMC shareholder, Stuart Sternberg (Tampa Bay Rays owner) is at all active with anything at ABMC??
👍️0
jw246802005 jw246802005 3 years ago
Head of Sales?

I would be curious to know who is the recent past AND current head of sales.

Then I'd like to hear the reasons why any sort of decent sales have never come to fruition.
👍️0
meluto meluto 3 years ago
Disappointment?

The stock price for anyone still holding is a very big disappointment.

I find it very curious that John J. Moroney who not that long ago was selling shares and got to below 5% has as already mentioned in this MB (and referenced below) come back to be working with them and now has the rest of his shares(much more than he sold) locked up; one has to wonder that he thinks that something of potential is being pursued.

8-K with John's renewed relationship with the company

Perhaps the risk/reward for a small amount of one's account could be considered again.


Melissa has been able to convince Stuart Sternberg and others on multiple occasions to buy shares; perhaps her skills can be used in a way to raise the stock price.
👍️0
One11 One11 3 years ago
Just stopping by for a laugh..
Bahahaha!
Melissa couldn't sell the porch furniture.
👍️0
BEIJING BILL BEIJING BILL 3 years ago
needs volume, dry er than americano jokes.
👍️0
RVfundage RVfundage 3 years ago
Who would buy a testing company that couldn't sell any tests during a pandemic?

NT 10K filed. Filings late again!
👍️0
tequilafan tequilafan 3 years ago
Looks interesting.Maybe ready,thanks!
👍️0
Ronin Ronin 3 years ago
8K out, this could rock!!


ABMC may be acquired, or looking to acquire?

https://www.otcmarkets.com/filing/html?id=15654022&guid=aVFwkKPx37w-B3h


ABMC chart:

https://www.barchart.com/stocks/quotes/ABMC


Float is 26M...

https://www.otcmarkets.com/stock/ABMC/security


ITEM 1.01 Entry into a Material Definitive Agreement

On March 7, 2022, American Bio Medica Corporation (the “Company”) entered into a Financial Advisory Agreement (the “Agreement”) with Landmark Pegasus, Inc. (‘Landmark”). The Agreement provides that Landmark will provide certain financial advisory services for a minimum period of 3 months (which period commenced on February 28, 2022), and as consideration for these services, the Company will pay Landmark (a) a retainer fee consisting of 500,000 restricted shares of common stock and a warrant to purchase 2.75 million shares of the Company’s common stock at a strike price equal to the average closing price of the Company’s common shares for the 30 days preceding the Agreement, or $0.035 per share, resulting in gross proceeds to the Company in the amount of $96,250.00. The warrant will vest upon the closing of a transaction involving Landmark or upon the invocation of a “Breakup Fee”.

The Breakup Fee will be invoked upon the generation of a specific transaction to ABMC which meets certain criteria agreed upon by both the Company and Landmark; which transaction is then rejected by the Company. The Company will also pay to Landmark a “Success Fee” for the consummation of a transaction closing during the term of the Agreement and for 12 months thereafter, between the Company and any party first introduced to the Company by Landmark, or with any party the Company has specifically requested Landmark’s assistance with the transaction.

Upon invocation of the Breakup Fee or payment of the Success Fee, the Company will also issue an additional 250,000 restricted shares of the Company’s common stock.

In the event that the Company consummates a transaction involving the provision of services to any party introduced to the Company by Landmark or with any party the Company has specifically requested Landmark’s assistance with, the Company will pay Landmark 10% of any revenues received from the transaction, unless this percentage is modified by both the Company and Landmark in writing.

There is no material relationship between the Company and Landmark, other than with respect to the Agreement.


👍️0

Your Recent History

Delayed Upgrade Clock